Endocrinol Metab.  2023 Oct;38(5):522-524. 10.3803/EnM.2023.502.

The Characteristics and Risk of Mortality in the Elderly Korean Population

• Suh S

• KMID: 2546982
• DOI: http://doi.org/10.3803/EnM.2023.502

Reference

1. Bae JH, Han KD, Ko SH, Yang YS, Choi JH, Choi KM, et al. Diabetes fact sheet in Korea 2021. Diabetes Metab J. 2022; 46:417–26.

2. Satman I, Bayirlioglu S, Okumus F, Erturk N, Yemenici M, Cinemre S, et al. Estimates and forecasts on the burden of prediabetes and diabetes in adult and elderly population in Turkiye. Eur J Epidemiol. 2023; 38:313–23.

3. Lee J, Kim HS, Song KH, Yoo SJ, Han K, Lee SH, et al. Risk of cause-specific mortality across glucose spectrum in elderly people: a nationwide population-based cohort study. Endocrinol Metab. 2023; 38:525–37.

4. Yang A, Shi M, Lau ES, Chow E, Chan JC. Trends in allcause and cause-specific mortality in older adults with and without diabetes: a territory-wide analysis in one million older adults in Hong Kong. Diabetes. 2023; 72(Supplement 1):1406–P.

5. Kang YM, Kim YJ, Park JY, Lee WJ, Jung CH. Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013. Cardiovasc Diabetol. 2016; 15:131.

6. Park SK, Park MK, Suk JH, Kim MK, Kim YK, Kim IJ, et al. Cause-of-death trends for diabetes mellitus over 10 years. Korean Diabetes J. 2009; 33:65–72.

7. Kim KJ, Kwon TY, Yu S, Seo JA, Kim NH, Choi KM, et al. Ten-year mortality trends for adults with and without diabetes mellitus in South Korea, 2003 to 2013. Diabetes Metab J. 2018; 42:394–401.

8. Shlomai G, Neel B, LeRoith D, Gallagher EJ. Type 2 diabetes mellitus and cancer: the role of pharmacotherapy. J Clin Oncol. 2016; 34:4261–9.

9. Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P, et al. Glycemic index, glycemic load, and chronic disease risk: a meta-analysis of observational studies. Am J Clin Nutr. 2008; 87:627–37.

10. Pearson-Stuttard J, Zhou B, Kontis V, Bentham J, Gunter MJ, Ezzati M. Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol. 2018; 6:e6–15.

11. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380:2224–60.

12. Suh S, Kim KW. Diabetes and cancer: cancer should be screened in routine diabetes assessment. Diabetes Metab J. 2019; 43:733–43.

13. Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of hyperglycemia in type 2 diabetes, 2022: a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022; 45:2753–86.